Abstract
Anti-GM1 and anti-GM1b antibodies are frequently present in patients with Guillain-Barré syndrome (GBS) and accordingly, the two antibodies often coexist in the same patient. In order to study clinical and laboratory features of anti-GM1b-positive GBS, we analyzed the data of patients with anti-GM1b IgG antibody but no anti-GM1 IgG antibody. Of 86 consecutive patients, 10 had anti-GM1b antibody alone and frequently had acute motor axonal neuropathy (AMAN, 80%) and Campylobacter jejuni infection (60%). Of 10 patients with anti-GM1 antibody alone, four had AMAN, and two had C. jejuni infection. These results showed that GM1b could be a target molecule of autoantibody in the AMAN form of GBS subsequent to C. jejuni infection.
Publication types
-
Comparative Study
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Adolescent
-
Adult
-
Aged
-
Aged, 80 and over
-
Antibodies / metabolism
-
Campylobacter Infections / immunology*
-
Campylobacter jejuni
-
Child
-
Child, Preschool
-
Enzyme-Linked Immunosorbent Assay / methods
-
Female
-
G(M1) Ganglioside / analogs & derivatives*
-
G(M1) Ganglioside / immunology*
-
G(M1) Ganglioside / metabolism
-
Gangliosidosis, GM1 / immunology
-
Gangliosidosis, GM1 / metabolism
-
Guillain-Barre Syndrome / classification
-
Guillain-Barre Syndrome / immunology*
-
Guillain-Barre Syndrome / metabolism
-
Guillain-Barre Syndrome / virology
-
Humans
-
Immunoglobulin G / immunology*
-
Male
-
Middle Aged
Substances
-
Antibodies
-
Immunoglobulin G
-
G(M1) Ganglioside
-
ganglioside M1b